SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sable Offshore
If you suffered losses exceeding $50,000 in Sable Offshore between May 19, 2025 and June 3, 2025 and/or pursuant to Sable's May 21, 2025 secondary public offering (the 'SPO') and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sable Offshore Corp. ('Sable Offshore' or the 'Company') (NYSE: SOC) and reminds investors of the September 26, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants represented that Sable Offshore Corp. had restarted oil production off the coast of California when it had not; and (2) as a result, Defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.
On May 28, 2025, Investing.com published an article entitled 'Sable Offshore Corp stock sinks following court injunction.' The article stated that Sable's stock had fallen after 'the California Coastal Commission was granted a preliminary injunction against the company's pipeline repair and maintenance activities within the coastal zone in unincorporated Santa Barbara County. The court's decision, which aligns with the Coastal Act's strict regulations on coastal development, has raised concerns about potential project delays and additional costs for Sable Offshore.'
On this news, Sable's stock fell $5.04 per share, or 15.3%, to close at $27.89 per share on May 28, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Sable Offshore's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Sable Offshore class action, go to www.faruqilaw.com/SOC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a84a685f-75cf-4fa0-96fb-36d460e70e1a
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
First Commonwealth Financial Corp (FCF) Q2 2025 Earnings Call Highlights: Surpassing ...
Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points First Commonwealth Financial Corp (NYSE:FCF) reported core earnings per share of $0.38, surpassing consensus estimates by $0.03. Net interest margin expanded significantly from 3.62% in the first quarter to 3.83% in the second quarter, driven by improved loan yields and lower deposit costs. Strong loan growth of 8.1% annualized, with broad-based performance in equipment finance, small business, commercial, indirect, and branch lending. Non-interest income increased by $2.1 million to $24.7 million, with strong contributions from mortgage, SBA, interchange, wealth, and other service charges. Successful integration of Centerbank, adding $295 million in loans and $278 million in deposits, enhancing presence in Cincinnati. Negative Points Non-performing loans increased by $40.1 million from the prior quarter, primarily due to a single commercial floor plan loan moved to non-accrual. Provision expense was $12.6 million, with $3.8 million tied to day one CSO provision for Center Bank. The cost of deposits fell by only 8 basis points, with increased borrowings by the end of the quarter. Potential pressure on loan spreads and the need to price deposits to fund loan growth could impact future margins. Limited buyback activity in the second quarter, with a cautious approach to share repurchases based on stock price. Q & A Highlights Warning! GuruFocus has detected 3 Warning Sign with FCF. Q: Did you provide a guidance range for expenses in the third quarter or the back half of the year? A: No specific guidance was given, but the consensus for the third quarter is $72.8 million and $73.1 million for the fourth quarter. There might be a slight tail-off in expenses and non-interest income in the fourth quarter due to seasonality, but they generally offset each other. Expenses are expected to bounce back in the first quarter of next year. - Jim Moreski, CFO Q: What is your approach to stock repurchases given the current stock price and new authorization? A: We plan to re-enter the market after the blackout period, setting a price cap for buybacks. Previously, we set a cap at $15.50 per share, but with the current higher prices, we might set it around $17. We aim to keep some dry powder for dips in the price rather than buying back shares at any cost. - Jim Moreski, CFO Q: Can you provide more color on the loan that drove the increase in non-performing loans (NPLs) and the outlook for charge-offs? A: The increase in NPLs was primarily due to a single commercial floor plan loan. Charge-offs have been at acceptable levels, and absent the one large relationship, we expect to return to a mid-20 basis point charge-off range. - Brian Sahoi, Chief Credit Officer Q: How are you thinking about mergers and acquisitions (M&A) given the current industry environment? A: We are open to smaller deals that offer low-risk execution and can be leveraged into something more significant. We have looked at many opportunities but tend to bow out on larger deals due to pricing. Our focus remains on strategic, smaller acquisitions that align with our business model. - Mike Price, President and CEO Q: What is the outlook for organic loan growth, particularly in the equipment finance portfolio? A: The pipeline looks strong, although there might be more payoffs in the third quarter. Equipment finance has shown good momentum, and while we expect the portfolio to flatten out in about a year and a half, we are pleased with the credit quality and assets being financed. - Mike Price, President and CEO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
40 minutes ago
- Yahoo
Retirement Dividend Stocks to Watch: The Case for Colgate-Palmolive Company (CL)
Colgate-Palmolive Company (NYSE:CL) is included among the 10 Best Dividend Stocks to Buy for Retirement. An array of toothpaste, toothbrushes, and mouthwashes on a bright background, highlighting the company's oral care products. Colgate-Palmolive Company (NYSE:CL) is a major player in the global household and personal care industry. The company holds a dominant position in the Oral Care segment. As of the current year, it commands a 40.9% share of the global toothpaste market and 31.9% in manual toothbrushes. Its products are available in more than 200 countries, reinforcing its widespread presence. Recently, the company has placed greater emphasis on sustainability efforts while continuing to strengthen its leadership across different product categories. Colgate-Palmolive Company (NYSE:CL) holds one of the strongest dividend histories in the market. The company has paid uninterrupted dividends to shareholders since 1895 and has raised its payouts for 62 years in a row. It currently offers a quarterly dividend of $0.52 per share for a dividend yield of 2.42%, as of July 30. It is among the best dividend stocks to invest in for retirement. While we acknowledge the potential of CL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Sign in to access your portfolio
Yahoo
40 minutes ago
- Yahoo
Johnson & Johnson's (JNJ) Long Dividend History Makes it a Strong Retirement Dividend Stock
Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Dividend Stocks to Buy for Retirement. A smiling baby with an array of baby care products in the foreground. Johnson & Johnson (NYSE:JNJ) stands out as a financially strong company, being one of only two firms globally with a perfect AAA credit rating, higher than that of the US government. By the end of the second quarter, it reported net debt of $32 billion, made up of $51 billion in total debt offset by $19 million in cash. This is relatively modest considering the company's market capitalization exceeds $400 billion. Johnson & Johnson (NYSE:JNJ)'s diversified healthcare operations produce strong and consistent cash flow. Last year, the company generated $20 billion in free cash flow, even after allocating around $17 billion toward research and development, roughly 19.4% of its total sales. This level of R&D spending placed the firm among the top investors in innovation across all industries. Despite its substantial R&D commitments, J&J still had more than enough free cash flow to cover its $11.8 billion in dividend payouts, leaving the company with significant surplus funds. Johnson & Johnson (NYSE:JNJ) holds a 63-year track record of consistent dividend growth, which makes it one of the best dividend stocks for retirement. The company currently offers a quarterly dividend of $1.30 per share and has a dividend yield of 3.11%, as of July 30. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
